Transgenic pigs produce functional human factor VIII in milk.
about
Precision editing of large animal genomesOviduct-specific expression of human neutrophil defensin 4 in lentivirally generated transgenic chickensGenetic engineering of a mouse: Dr. Frank Ruddle and somatic cell geneticsCould protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?Animal transgenesis: state of the art and applications.Home management of haemophilia.Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide.Therapy for haemophilia: recent advances and goals for the future.Transgenic animals as drug factories: a new source of recombinant protein therapeutics.Pigs taking wing with transposons and recombinases.The promise and challenges of bioengineered recombinant clotting factors.Functional factor VIII made with von Willebrand factor at high levels in transgenic milkGenetic modifications of pigs for medicine and agriculture.New treatments in hemophilia: insights for the clinician.Novel drugs to treat hemophilia.Transgenic mammalian species, generated by somatic cell cloning, in biomedicine, biopharmaceutical industry and human nutrition/dietetics--recent achievements.Blood Clotting Factor VIII: From Evolution to Therapy.Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.Expression systems and species used for transgenic animal bioreactors.Ultrastructural morphometry of mammary gland in transgenic and non-transgenic rabbits.Expression of Active Fluorophore Proteins in the Milk of Transgenic Pigs Bypassing the Secretory Pathway.Efficient stabilization of recombinant human coagulation factor VIII in the milk of transgenic mice using hFVIII and vWF co-expression vector transduction.Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle.Establishment of a novel, eco-friendly transgenic pig model using porcine pancreatic amylase promoter-driven fungal cellulase transgenes.
P2860
Q24611750-6357A9FD-667F-4E4C-B578-A01EB99CD1B6Q28547573-104C66A0-4D2E-4CDC-8CF2-88190A2D6922Q28743531-476B06D6-97F6-404D-B196-091C60FC3FCCQ33987983-DB3211C4-63B0-463A-9B48-778B46564080Q34608788-8E72E88B-3DD9-4A01-882A-754F7013BC74Q35666730-2718B062-D8FE-41CB-BE84-B3F79F039DADQ35915662-C3732A92-916B-4F68-927A-1E7B5DFDDB20Q36066048-BE166C06-F3C9-41CF-80D8-2CAFA0DE4659Q36181123-90160FB8-FC43-4E02-9D2C-9786AA091412Q36187528-FB174E3A-9617-4466-A748-27642B4CCD1AQ36230850-8656DC51-77E8-4AA2-A2FF-50F469ED720BQ36239576-3F1F24B6-A7C9-46E3-ACD8-640C0BA4332EQ36466394-3495D75F-70BB-4AD2-AD96-5F5C30BC1EAEQ36612681-FA0941BE-9747-47B2-8EC5-AEB89C44C0ACQ37775029-BB1CF9B8-4B51-4764-B55B-6267E9DEA7DAQ37896586-785357C6-4032-4E33-B737-6D3401A1A71EQ38118763-EEB69F65-FADE-449F-ABFA-9C5E32A8C3D8Q38901709-C83B9621-09B8-4B57-8268-BA13CCECC9A2Q39468670-F0EAE793-7402-42A9-B7C3-C207620F9C6AQ39777871-8529B4F2-BDA9-4CA8-AC74-F6DD3C7F6A0AQ40271068-CEEDA1AE-060A-4A56-923E-B88B7F129A00Q42161184-DBA56C3C-4976-4D6E-929B-4DF6703D21B4Q43569961-D51EAF5B-5239-47C6-8212-6E746D019A83Q51066225-24E81670-B2D6-47B9-ACD2-30AA17022D42
P2860
Transgenic pigs produce functional human factor VIII in milk.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Transgenic pigs produce functional human factor VIII in milk.
@en
Transgenic pigs produce functional human factor VIII in milk.
@nl
type
label
Transgenic pigs produce functional human factor VIII in milk.
@en
Transgenic pigs produce functional human factor VIII in milk.
@nl
prefLabel
Transgenic pigs produce functional human factor VIII in milk.
@en
Transgenic pigs produce functional human factor VIII in milk.
@nl
P2093
P2860
P356
P1433
P1476
Transgenic pigs produce functional human factor VIII in milk.
@en
P2093
Gwazdauskas FC
Paleyanda RK
Scandella DH
Velander WH
P2860
P2888
P304
P356
10.1038/NBT1097-971
P577
1997-10-01T00:00:00Z
P5875
P6179
1021018372